Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Insider Filings - GRANADILLO PEDRO P
Last Updated 
24-Nov-09
Enter symbol:
symbol lookup
 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GRANADILLO PEDRO P: Declared Holdings
Company/RelationshipReportedShares  Ownership
Dendreon Corporation
Director
NasdaqGM:DNDN
(historical quotes, profile, SEC, other insiders) 		7-Oct-094,994  Direct

Director
FINB 		2-Jan-080  Direct
HAEMONETICS CP
Director
NYSE:HAE
(historical quotes, profile, SEC, other insiders) 		30-Jul-0910,308  Direct
NOVEN PHARMACEUTICALS INC
Director
NOVN 		27-Aug-090  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
7-Oct-09 4,994DNDN Acquisition (Non Open Market) at $0 per share.
27-Aug-09 9,120NOVN Disposition (Non Open Market) at $16.50 per share.
(Value of $150,480)
20-Aug-09 32,817NOVN Disposition (Non Open Market) at $16.50 per share.
(Value of $541,480)
30-Jul-09 367HAE Acquisition (Non Open Market) at $0.01 per share.
(Value of $3)
22-May-09 12,160NOVN Acquisition (Non Open Market) at $0 per share.
5-Nov-08 3,500HAE Purchase at $57.95 per share.
(Cost of $202,825)
31-Jul-08 354HAE Acquisition (Non Open Market) at $0.01 per share.
(Value of $3)
5-Jun-08 10,121NOVN Acquisition (Non Open Market) at $0 per share.
2-Jun-08 4,400NOVN Purchase at $11.40 - $11.42 per share.
(Cost of about $50,000)
13-May-08 5,000NOVN Purchase at $9.89 per share.
(Cost of $49,450)
5-May-08 1,800HAE Purchase at $53.59 per share.
(Cost of $96,462)
2-Jan-08 6,885FINB Disposition (Non Open Market) at $32 per share.
(Value of $220,320)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?